Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFE-ACS: Sodium Thiosulfate in Acute Coronary Syndrome
NCT03017963Phase 2Completed
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium thiosulfate in acute coronary syndrome (ACS), sponsored by University Medical Center Groningen. Started Oct 2017; status: completed.
02
Drugs
sodium thiosulfate
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT03017963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03017963.